Antipsychotics

Based on the studies cited, it seems hard to support the assertion that “early initiation of antipsychotics may improve long-term course of the illness.” This raises an urgent question about initial treatment. Doesn’t it make sense to try to capture all of those individuals who might get through a psychosis without drugs?

From the Lown Institute: For pharmaceutical companies who use scare tactics to sell drugs, every day is like Halloween. This list of egregious advertisements shows...

How does physical activity affect people diagnosed with bipolar, schizophrenia and major depressive disorders?

The authors of the report expand upon the traumatic and sociopolitical factors underlying presentations of psychosis and “schizophrenia.”

Psychologists and people with experience of psychotic symptoms publish a report on new ways of understanding psychosis.

Analysis of longitudinal data from 2000-2014 demonstrate mortality gap is widening between persons with a diagnosis of bipolar or schizophrenia compared to the general population

From The Foundation for Excellence in Mental Health Care: The Hearing Voices Research and Development Fund has been awarded a $300,000 grant to expand their...

Re-conceptualizing the Clinical-High-Risk/Ultra-High-Risk Paradigm: A critique and reappraisal

From Pacific Standard: A new study surveyed people who have come off psychiatric medications to come up with information doctors can use to help support their...

Large cohort studies of people with a first-episode psychosis provide a unique opportunity for finding out why so many young people with schizophrenia spectrum disorders die at a young age. However, it seems that those psychiatrists who have access to the mortality data generally do not want the facts to come out.

A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.

In this post for Better Health While Aging, Dr. Leslie Kernisan discusses the importance of making sure that older adults are taking the minimum amount...

One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.

On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...

From UPI: A team of researchers from the University of Texas Southwestern Medical Center found that the serotonin 2c receptor is responsible for weight gain...

From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company...

Large cohort study demonstrates that those with an intellectual disability are at an increased risk for movement disorder side effects of antipsychotics.

14-year study of a rural sample in China shows those who were married had higher rates of remission from schizophrenia.

20-year follow-up study finds that after four years, patients not prescribed antipsychotics have significantly better work functioning.

From Psychiatry Advisor: Childhood trauma modulates the effects of bipolar disorder on the amygdala and hippocampus; it is associated with increased volumes of gray matter. "'Childhood maltreatment has...

Re-examination of meta-analytic claims finds the prevalence of pediatric bipolar disorder is close to zero.

From Yahoo! News: Nine months ago, Matt Amsler, a 24-year-old father, mysteriously disappeared after undergoing a bad reaction to antipsychotics. His body has been found...

A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.

From Kirkus Reviews: In his new book Mental Health, Inc., Art Levine reports on the dire state of the U.S. mental health system. "The author delivers the...

No placebo controlled trials provide evidence of antipsychotics in first-episode psychosis.